Casandra
Casandra Test Code QD00463Version 1 (DRAFT)
Performing Lab
Lab Quest DiagnosticsLab Test ID 39391
Drug Monitoring, Buprenorphine and Naloxone, Quantitative, Urine
Also known as: Suboxone®, Pain Management, Prescription Drug Monitoring
Clinical Use
Order TestUse
This quantitative urine drug monitoring test measures buprenorphine, its primary metabolite norbuprenorphine, and naloxone to assess patient adherence to treatment regimens involving buprenorphine/naloxone formulations. It supports clinical decisions regarding compliance, potential diversion, and proper medication use.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Mass Spectrometry
Biomarkers
Buprenorphine
AnalyteBuprenorphine • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Naloxone
AnalyteNaloxone • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Norbuprenorphine
AnalyteNorbuprenorphine • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Other
Volume
10 mL (9 mL minimum)
Minimum Volume
Not provided
Container
plastic urine container
Collection Instructions
random urine
Causes for Rejection
preserved urine
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 5 days |
| Refrigerated | 7 days |
| Frozen | 30 days |